Vertex Pharmaceuticals Inc VRTX:NASDAQ

Last Price$177.14NASDAQ Previous Close - Last Trade as of 4:00PM ET 7/17/19

Today's Change+0.98(0.56%)
Bid (Size)$173.40 (1)
Ask (Size)$180.03 (1)
Day Low / High$176.33 - 179.24
Volume773.1 K
  • Latest Stories
  • Commentary and Analysis
Sector Update: Health Care Stocks End on Positive Ground
4:07PM ET 6/21/2019 MT Newswires

Top Health Care Stocks JNJ -0.05% PFE +0.87% ABT +0.16% MRK 0.00% AMGN +0.84% Health care stocks closed moderately higher this afternoon, turning...

Sector Update: Health Care
3:55PM ET 6/21/2019 MT Newswires

Health care stocks were moderately higher this afternoon, turning around their prior declines. At last look, the NYSE Health Care Index was rising almost...

FDA Clears Vertex Pharma's Cymdeko for Cystic Fibrosis Patients Ages 6 Years and Older
2:48PM ET 6/21/2019 MT Newswires

Vertex Pharmaceuticals (VRTX) was narrowly higher this afternoon, reversing a nearly 1% decline earlier Friday, after the US Food and Drug Administration...

Sector Update: Biotechs Lift Health Care Stocks to Large Gain
3:55PM ET 6/07/2019 MT Newswires

Top Health Care Stocks JNJ +1.70% PFE +0.80% ABT +1.07% MRK +1.38% AMGN +0.67% Health care stocks were ending near their session highs, with the NYSE...

Sector Update: Health Care Stocks Climbing More Than 1% as a Group
1:59PM ET 6/07/2019 MT Newswires

Top Health Care Stocks JNJ +1.71% PFE +0.82% ABT +0.77% MRK +1.35% AMGN +0.32% Health care stocks were posting large gains, including a 1.3% advance...

Vertex Pharmaceuticals Expands Collaboration with CRISPR, Buys Exonics Therapeutics
11:00PM ET 6/06/2019 MT Newswires

Vertex Pharmaceuticals (VRTX) said it expanded its collaboration with CRISPR Therapeutics (CRSP) and acquired Exonics Therapeutics to enhance its gene...

Vertex Pharma to Seek Approvals for Triple Combination of VX-445, Tezacaftor and Ivacaftor in Cystic Fibrosis - Stock Up 2%
1:29PM ET 5/30/2019 MT Newswires

Vertex Pharmaceuticals (VRTX) said on Thursday it has selected the triple combination of the next-generation corrector VX-445, tezacaftor and ivacaftor to...

OPTIONS: Option Implied Volatility into Annual Meeting of the American Society of Clinical Oncology
5:57AM ET 5/24/2019 MT Newswires

Option implied volatility into Annual Meeting of the American Society of Clinical Oncology, or ASCO, on May 31-June 4 Alexion Pharmaceuticals (ALXN) 30-day...

Analyst Actions: Credit Suisse Starts Vertex Pharmaceuticals at Outperform, With $209 Price Target
8:57AM ET 5/21/2019 MT Newswires

Vertex Pharmaceuticals' (VRTX) average rating among analysts is a buy, with an average price target of $204. Price: 165.73, Change: 0.00, Percent Change:...

Kymera Therapeutics to Receive $70 Mln Equity Interest From Vertex Pharmaceuticals Partnership
10:58AM ET 5/15/2019 MT Newswires

Vertex Pharmaceuticals (VRTX) and Kymera Therapeutics have agreed to a four-year research and development collaboration, under which Kymera gets a $70...